White or pale yellow crystalline powder;
Residue on Ignition≤0.2%
Content (C20H24FN3O4) ≥ 99.0%.
A new generation of quinolone antibiotics;
For acute bronchitis, acute exacerbation of chronic bronchitis, pneumonia and other respiratory system infections caused by bacteria and atypical pathogens that are sensitive to this product; Systemic infections; gastrointestinal infections such as typhoid fever, Salmonella, bacillary dysentery; skin and soft tissue infections, bone infections, abdominal infections, etc.